about
The quest for biomarkers in IBS-where should it lead us?Irritable bowel syndrome: a clinical reviewValidating biomarkers of treatable mechanisms in irritable bowel syndromeIrritable bowel syndrome: how useful is the term and the 'diagnosis'?Performance characteristics of the measurement of gastric volume using single photon emission computed tomography.Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipationA Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.The role of experimental models in developing new treatments for irritable bowel syndrome.Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.Methods for the assessment of small-bowel and colonic transit.How to interpret a functional or motility test - colon transit study.Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders.Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations.Drug development for the irritable bowel syndrome: current challenges and future perspectivesRandomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation.Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practiceThe role of pharmacogenetics in nonmalignant gastrointestinal diseases.Elobixibat for the treatment of constipation.Diagnostic criteria in IBS: useful or not?The search for biomarkers and endophenotypes in functional gastrointestinal disorders.Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation.Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
P2860
Q27024239-716C585B-F84B-4CB8-BD18-21AB6892E239Q34168517-A64DDCBD-0ED5-4D0C-9519-C096A4297E76Q34577283-A313D35F-059F-44DD-A866-2F143A9C4EEBQ34645419-758D6B3D-9820-46BD-9D1F-E9E1757528AAQ35017235-B4ED7219-A464-40FC-AD6F-390F33197D56Q35018425-E4EAC3A6-A387-41AC-9F8B-44897C93CDDFQ35028313-445D0760-6E07-4711-A05E-21B8B64FA81BQ35071310-C29E01F1-526B-4EF4-A935-D541316A1DCEQ35309093-9019CE75-A4B3-4407-AA21-1A3CFAF25C2BQ35724278-84DF7546-8868-41E5-8A7F-53BF5442CE83Q35730582-FCA9864C-6686-4F6F-B679-52656DEA6EE6Q36021269-6404A182-988D-4BC5-9136-93B7DF46FE0AQ36082843-57A95691-93FF-4812-B280-D27960A0F936Q36487263-461C9F53-2572-491C-B0C9-5F5640FC701EQ36579818-D34AF0A5-DAED-419E-8ABC-5037385A1646Q37178858-311FDE27-557C-47E6-B3F2-E2580B2A001CQ37259375-EE4C7273-C5D6-466F-849D-DF8C499BD525Q37270032-B508AFA0-E074-454A-AB67-EB9F089C5AF9Q37396985-7DA64A41-E7D7-4906-89A1-E70FD1A5F4D4Q37981892-BB96E80E-0AF7-4A6D-A950-EA5CC552A9ECQ38065210-C6F1F491-7003-4C7D-B795-1D31850CF083Q39566201-E8CB6B3C-04BA-4108-931B-916D194B2FAFQ42870005-1855E833-63F6-4138-B171-E1CA88FAA6B8Q43355511-9F700D55-8B32-4B96-BBDF-3A7065758AAEQ51318198-6EEE8892-B9E1-4B17-A6B4-94DEA5FF80BDQ51368980-88E281CA-072C-4013-A3D6-03892D080DE4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Scintigraphic biomarkers for colonic dysmotility.
@ast
Scintigraphic biomarkers for colonic dysmotility.
@en
type
label
Scintigraphic biomarkers for colonic dysmotility.
@ast
Scintigraphic biomarkers for colonic dysmotility.
@en
prefLabel
Scintigraphic biomarkers for colonic dysmotility.
@ast
Scintigraphic biomarkers for colonic dysmotility.
@en
P2860
P356
P1476
Scintigraphic biomarkers for colonic dysmotility.
@en
P2093
M Camilleri
P2860
P304
P356
10.1038/CLPT.2010.23
P407
P577
2010-04-21T00:00:00Z